PLYX
Polaryx Therapeutics, Inc.
1.90$
-3.6%
vs. previous close
Closing price · As of: Nov 12, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Polaryx Therapeutics, Inc. (PLYX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/11/2026 | Current report (8-K) | Polaryx Therapeutics, Inc. (PLYX): Submission of Matters to a Vote of Security Holders | View report ↗ |
| 09/01/2026 | Current report (8-K) | Polaryx Therapeutics, Inc. (PLYX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.